Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Amikacin inhalation solution (BAY41-6551)
DRUG
2 trials
Sponsors
Bayer
Conditions
Pneumonia
Pneumonia, Bacterial
Phase 2
Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia
Completed
NCT01021436
Bayer
Pneumonia
Start: 2007-03-31
End: 2007-08-31
Updated: 2016-02-18
Phase 3
Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Completed
NCT01799993
Bayer
Pneumonia, Bacterial
Start: 2013-04-13
End: 2017-04-07
Updated: 2018-07-23
Related Papers
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
2019-12-19
80 citations
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia.
2009-12-10
96 citations